Fig. 2From: Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide studyThe predicted 10-year survival in female cancer patients with different time intervals to treatment. A stage I NSCLC, B stage II NSCLC, C stage I infiltrating breast cancer, D stage II infiltrating breast cancer, NSCLC non-small cell lung cancerBack to article page